We are live on ! Find out more
DAM

Doheny Asset Management Portfolio holdings

AUM $153M
1-Year Est. Return 42.04%
This Fund
S&P 500
This Quarter Est. Return
+23.68%
1 Year Est. Return
+42.04%
3 Year Est. Return
+121.4%
5 Year Est. Return
10 Year Est. Return
AUM
$144M
AUM Growth
+$22.9M
Cap. Flow
+$1.6M
Cap. Flow %
1.11%
Top 10 Hldgs %
40.38%
Holding
106
New
12
Increased
21
Reduced
43
Closed
8

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$1.87M
2
ENPH icon
Enphase Energy
ENPH
+$1.5M
3
SFL icon
SFL Corp
SFL
+$1.01M
4
BAC icon
Bank of America
BAC
+$884K
5
WATT icon
Energous
WATT
+$735K

Sector Composition

Rank Sector Weight
1 Technology 38.08%
2 Healthcare 14.58%
3 Communication Services 11.21%
4 Consumer Discretionary 6.68%
5 Financials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GH icon
76
Guardant Health
GH
$21.9B
$372K 0.26%
+2,890
New +$333K
SWK icon
77
Stanley Black & Decker
SWK
$15.6B
$360K 0.25%
2,014
XLNX
78
DELISTED
Xilinx Inc
XLNX
$354K 0.25%
2,500
-500
-17% -$65K
FROG icon
79
JFrog
FROG
$10.2B
$349K 0.24%
5,550
-50
-0.9% -$3.48K
SPLK
80
DELISTED
Splunk Inc
SPLK
$346K 0.24%
+2,035
New +$389K
CNI icon
81
Canadian National Railway
CNI
$77.1B
$330K 0.23%
3,000
VRTX icon
82
Vertex Pharmaceuticals
VRTX
$123B
$325K 0.23%
+1,375
New +$315K
USB icon
83
US Bancorp
USB
$100B
$324K 0.23%
6,961
-500
-7% -$21.2K
SFL icon
84
SFL Corp
SFL
$1.58B
$319K 0.22%
50,800
-145,883
-74% -$1.01M
PFE icon
85
Pfizer
PFE
$147B
$304K 0.21%
8,247
-19,259
-70% -$706K
GD icon
86
General Dynamics
GD
$104B
$298K 0.21%
2,000
BMY icon
87
Bristol-Myers Squibb
BMY
$130B
$283K 0.2%
4,559
-4,404
-49% -$271K
MDLZ icon
88
Mondelez International
MDLZ
$79.9B
$278K 0.19%
4,750
APTO
89
DELISTED
Aptose Biosciences, Inc.
APTO
$278K 0.19%
141
-55
-28% -$129K
HAL icon
90
Halliburton
HAL
$26.6B
$244K 0.17%
12,919
-351
-3% -$5.45K
COP icon
91
ConocoPhillips
COP
$140B
$234K 0.16%
+5,845
New +$215K
EW icon
92
Edwards Lifesciences
EW
$51.2B
$233K 0.16%
2,550
-150
-6% -$12.4K
ENB icon
93
Enbridge
ENB
$113B
$231K 0.16%
7,232
BLUE
94
DELISTED
bluebird bio
BLUE
$229K 0.16%
+409
New +$259K
RTX icon
95
RTX Corp
RTX
$300B
$224K 0.16%
3,137
-681
-18% -$44.8K
CMBT
96
CMB.TECH NV
CMBT
$4.62B
$221K 0.15%
27,600
-1,500
-5% -$12.3K
CUE icon
97
Cue Biopharma
CUE
$112M
$152K 0.11%
405
-72
-15% -$28.8K
WATT icon
98
Energous
WATT
$98.4M
$142K 0.1%
131
-557
-81% -$735K
BAC icon
99
Bank of America
BAC
$442B
-36,680
Closed -$884K
ERIC icon
100
Ericsson
ERIC
$33B
-14,130
Closed -$154K

Similar funds

Doheny Asset Management's Q4 2020 Portfolio in Review

As of Q4 2020, Doheny Asset Management held 106 positions worth $144M, up 19% from $121M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Doheny Asset Management's Q4 2020 filing shows 12 new, 21 increased, 43 reduced and 8 closed positions. Its largest new stake was DraftKings: 41,581 shares worth $1.94M. The largest sale was Gilead Sciences, an estimated $1.87M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 38% a quarter earlier, followed by Healthcare and Communication Services.

  • Doheny Asset Management's largest Q4 2020 buy was DraftKings: 41,581 shares worth $1.94M.
  • Doheny Asset Management added most to Broadmark Realty Capital Inc. Common Stock in Q4 2020, an estimated $1.02M increase.
  • Doheny Asset Management's biggest Q4 2020 reduction was Gilead Sciences, cutting an estimated $1.87M.
  • Doheny Asset Management fully exited Bank of America in Q4 2020, selling an estimated $884K.
  • Doheny Asset Management's ten largest holdings make up 40% of its $144M portfolio in Q4 2020.
  • Doheny Asset Management opened 12 new positions and closed 8 in Q4 2020.
  • Doheny Asset Management's portfolio value rose 19% quarter-over-quarter to $144M.

Based on Doheny Asset Management's 13F filing for Q4 2020, filed 26 Feb 2021.